Nurse Practitioner, Family · Indianapolis, IN
NPI
1861086803
Since 2021
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
8711 US 31
Indianapolis, IN, 46227
Phone (317) 887-7771
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
556 services
Medicare patients, 2024
358
Average age 74
Drug cost, 2024
$420K
1,281 prescriptions
Company payments, 2025
$6,017
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sara Reischman was code 99214 (office e&m - established), 226 times for 166 patients. In total Sara Reischman billed 556 services in 8 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 226 | 166 | $70.04 | $16K |
| 99231 Hospital E&M - Subsequent | Facility | 152 | 93 | $29.84 | $4,536 |
| 99213 Office E&M - Established | Office | 96 | 84 | $48.88 | $4,692 |
| 99222 Hospital E&M - Initial | Facility | 56 | 54 | $77.58 | $4,345 |
| 99204 Office E&M - New | Office | 14 | 14 | $93.30 | $1,306 |
By year: 2023 $18K for 271 services; 2024 $31K for 556 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sara Reischman prescribed most often to Medicare patients was Omeprazole, with 195 prescriptions and refills. In total Sara Reischman wrote 1,281 Medicare prescriptions that cost $420K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 195 | 559 | 77 | $4,580 |
| Pantoprazole Sodium Generic | 189 | 540 | 82 | $2,305 |
| Famotidine Generic | 163 | 446 | 66 | $3,144 |
| Dicyclomine Hcl Generic | 109 | 193 | 44 | $2,407 |
| Ondansetron Odt Ondansetron | 80 | 85 | 34 | $2,337 |
| Colestipol Hcl Generic | 79 | 175 | 35 | $5,845 |
| Linzess Linaclotide | 37 | 83 | 13 | $45K |
| Xifaxan Rifaximin | 35 | 35 | 11 | $107K |
| Esomeprazole Magnesium Generic | 33 | 65 | Under 11 | $5,182 |
| Dexlansoprazole Dr Dexlansoprazole | 32 | 88 | 12 | $6,510 |
| Movantik Naloxegol Oxalate | 27 | 27 | Under 11 | $11K |
| Sucralfate Generic | 25 | 56 | Under 11 | $2,913 |
| Lubiprostone Generic | 20 | 27 | Under 11 | $1,146 |
| Mesalamine Generic | 17 | 45 | Under 11 | $6,565 |
| Lactulose Generic | 17 | 21 | Under 11 | $554 |
Brand drugs: - claims; generic drugs: 1,097 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sara Reischman $6,017 ($6,017 in general payments such as food, travel and fees) from 23 companies. The largest payer was Abbvie Inc. with $1,130.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 52 | $1,130 |
| NeurAxis, Inc. NRXS | 1 | $940 |
| Janssen Biotech, Inc. JNJ | 31 | $703 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 29 | $542 |
| Madrigal Pharmaceuticals MDGL | 8 | $463 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 21 | $407 |
| Lilly USA, LLC LLY | 14 | $294 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $268 |
| Ardelyx, Inc. ARDX | 13 | $259 |
| Genzyme Corporation SNY | 4 | $176 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.